The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.
Open accessAbstract
The synthetic peptides DP-107 and DP-178 (T-20), derived from separate domains within the human immunodeficiency virus type 1 (HIV-1) transmembrane (TM) protein, gp4l, are stable and potent inhibitors of HIV-1 infection and fusion. Using a computer searching strategy (computerized antiviral searching technology, C.A.S.T.) based on the predicted secondary structure of DP-107 and DP-178 (T-20), we have identified conserved heptad repeat domains analogous to the DP-107 and DP-178 regions of HIV-1 gp41 within the glycoproteins of other fusogenic viruses. Here we report on antiviral peptides derived from three representative paramyxoviruses, respiratory syncytial virus (RSV), human parainfluenza virus type 3 (HPIV-3), and measles virus (MV). We screened crude preparations of synthetic 35-residue peptides, scanning the DP-178-like domains, in antiviral assays. Peptide preparations demonstrating antiviral activity were purified and tested for their ability to block syncytium formation. Representative DP-178-like peptides from each paramyxovirus blocked homologous virus-mediated syncytium formation and exhibited EC50 values in the range 0.015-0.250 microM. Moreover, these peptides were highly selective for the virus of origin. Identification of biologically active peptides derived from domains within paramyxovirus F1 proteins analogous to the DP-178 domain of HIV-1 gp4l is compelling evidence for equivalent structural and functional features between retroviral and paramyxoviral fusion proteins. These antiviral peptides provide a novel approach to the development of targeted therapies for paramyxovirus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acids
FIELDS, G. B., & NOBLE, R. L. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00939.x · Cited by 2,493
Wilschut, J. (1990) · Cited by 2,407
Structure of influenza haemagglutinin at the pH of membrane fusion
Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994) · Nature · doi:10.1038/371037a0 · Cited by 1,564
Scheid, A., & Choppin, P. W. (1974) · Virology · doi:10.1016/0042-6822(74)90187-1 · Cited by 911
A spring-loaded mechanism for the conformational change of influenza hemagglutinin
Carr, C. M., & Kim, P. S. (1993) · Cell · doi:10.1016/0092-8674(93)90260-w · Cited by 857
A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis
KING, D. S., FIELDS, C. G., & FIELDS, G. B. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00976.x · Cited by 725
Weislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H., & Boyd, M. R. (1989) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.577 · Cited by 685
White, J. M. (1992) · Science · doi:10.1126/science.1439803 · Cited by 628
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
Viral and Cellular Membrane Fusion Proteins
White, J. M. (1990) · Annual Review of Physiology · doi:10.1146/annurev.ph.52.030190.003331 · Cited by 522
Jiang, S., Lin, K., Strick, N., & Neurath, A. R. (1993) · Nature · doi:10.1038/365113a0 · Cited by 508
Wild, C., Oas, T., McDanal, C., Bolognesi, D., & Matthews, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10537 · Cited by 485
Characterization of gp41 as the Transmembrane Protein Coded by the HTLV-III/LAV Envelope Gene
Veronese, F. D., DeVico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1985) · Science · doi:10.1126/science.2994223 · Cited by 437
Paramyxovirus Fusion: A Hypothesis for Changes
Lamb, R. A. (1993) · Virology · doi:10.1006/viro.1993.1561 · Cited by 418
A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion
Wild, C., Greenwell, T., & Matthews, T. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1051 · Cited by 398
Stabilization of the ribonuclease S‐peptide α‐helix by trifluoroethanol
Nelson, J. W., & Kallenbach, N. R. (1986) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340010303 · Cited by 387
Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses
Scheid, A., & Choppin, P. W. (1977) · Virology · doi:10.1016/0042-6822(77)90380-4 · Cited by 370
A General Model for the Transmembrane Proteins of HIV and Other Retroviruses
GALLAHER, W. R., BALL, J. M., GARRY, R. F., GRIFFIN, M. C., & MONTELARO, R. C. (1989) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1989.5.431 · Cited by 368
Chang, C., & Meienhofer, J. (1978) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1978.tb02845.x · Cited by 304
Chambers, P., Pringle, C. R., & Easton, A. J. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-12-3075 · Cited by 299
Hart, T. K., Kirsh, R., Ellens, H., Sweet, R. W., Lambert, D. M., Petteway, S. R., Leary, J., & Bugelski, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2189 · Cited by 204
Self-citationMatthews, T. J., Langlois, A. J., Robey, W. G., Chang, N. T., Gallo, R. C., Fischinger, P. J., & Bolognesi, D. P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9709 · Cited by 203
Wild, C., Dubay, J. W., Greenwell, T., Baird, T., Oas, T. G., McDanal, C., Hunter, E., & Matthews, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12676 · Cited by 200
Chen, C. H., Matthews, T. J., McDanal, C. B., Bolognesi, D. P., & Greenberg, M. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3771-3777.1995 · Cited by 169
Buckland, R., & Wild, F. T. (1989) · Nature · doi:10.1038/338547a0 · Cited by 126
Helix propagation in trifluoroethanol solutions
Storrs, R. W., Truckses, D. M., & Wemmer, D. E. (1992) · Biopolymers · doi:10.1002/bip.360321211 · Cited by 103
Buckland, R., Malvoisin, E., Beauverger, P., & Wild, F. T. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-7-1703 · Cited by 102
Dubay, J. W., Dubay, S. R., Shin, H., & Hunter, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4675-4682.1995 · Cited by 79
Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein
Reitter, J. N., Sergel, T. A., & Morrison, T. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.5995-6004.1995 · Cited by 79
Structural Rearrangements in the Transmembrane Glycoprotein after Receptor Binding
Matthews, T. J., Wild, C. T., Chen, C., Bolognesi, D. P., & Greenberg, M. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00866.x · Cited by 63
Wang, C., Raghu, G., Morrison, T. G., & Peeples, M. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4161-4169.1992 · Cited by 28
Cited by
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Bosch, B. J., van der Zee, R., de Haan, C. A. M., & Rottier, P. J. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8801-8811.2003 · Cited by 1,489
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Henrickson, K. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.242-264.2003 · Cited by 498
Metadata
- Authors
- Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., & Petteway, S. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-03-05
- Volume
- 93
- Issue
- 5
- Pages
- 2186-2191
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2012735516
- Cited by
- 336
- References
- 31
- FWCI
- 13.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.